Aspects of clinical research such as evidence‐based medicine, methodology, statistics and
ethics are addressed in this section, as well as drug development for small populations and
the regulatory procedures available for drug licensing.
Markku Toivonen Toivonen, MD, PhD Scientific Director NDA Regulatory Science Ltd gives a presentation entiled Clinical trials: When and why? ...
ViewRob Camp introducing the history of orphan drug regulation in the USA at the FDA...
ViewDr Ferran Torres Statistics and Methodology Support Unit, Hospital Clinic, Barcelona on the Analysis and Interpretation of Clinical Trials...
ViewDr. Eric Koster speaks gives a presentation entitles ethical aspects of medical research involving human subjects...
ViewMarkku Toivonen Toivonen, MD, PhD Scientific Director NDA Regulatory Science Ltd gives a presentation entiled Clinical Trials in Non-Standard Situations...
ViewJulia Saperia, European Medicines Agency introduces the European paediatric regulation...
ViewFabrizia Bignami introduces the EURORDIS Clinical Trials Charter...
ViewMarkku Toivonen Toivonen, MD, PhD Scientific Director NDA Regulatory Science Ltd...
View